Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Crown Bio Announces Expansion | Contract Pharma

What are you searching for?

Sign in
Breaking News

Crown Bio Announces Expansion

Of its existing portfolio of humanized drug target models (HuGEMM™) to its San Diego research facility

By: Betsy Louda

, Contract Pharma

Crown Bioscience is extending its existing portfolio of humanized drug target models (HuGEMM™) to its San Diego facility.


This service offering expansion to the San Diego site will begin with humanized PD-1, PD-L1, CTLA-4, OX40, CD137, PD-1/PD-L1, and PD-1/CTLA-4 targets. Additional HuGEMM™ models will follow later this year to help advance development of immuno-oncology (I/O) drugs.

The expansion of this novel translational platform to CrownBio’s San Diego laboratory makes it more accessible to both the North American and worldwide research community. 
CrownBio provides the biopharmaceutical research community with innovative preclinical platforms to evaluate human-specific immunotherapies in vivo, while shortening experimental timelines and mitigating costs. The HuGEMM portfolio helps achieve this by featuring fully functional murine immunity with a humanized drug target that can be used in conjunction with syngeneic/homograft mouse tumors.

“Our HuGEMM portfolio is uniquely positioned to expedite study timelines, save researcher’s money and deliver valuable insights about targeted immunotherapies,” said Henry Li, PhD, senior vice president of Global Scientific Research and Innovation. “We are very excited about continuing to grow this platform and to make it more available to scientists globally via the expansion of our San Diego laboratory.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics